Noah Holdings Ltd
NOAH NYSE Investment Advice Financials FY2016–FY2025
What Noah Holdings Ltd does
No business description yet.
- Legal name
- NOAH HOLDINGS LTD
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Apr 29, 2026
- Accession · CIK
- 0001104659-26-050892
0001499543
Revenue and margins
Noah Holdings Ltd had $363M of revenue in fiscal 2025, up 0.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew −26.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $117M in fiscal 2025, 32.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Noah Holdings Ltd returned $83.3M to shareholders in fiscal 2025, 71% of free cash flow. The diluted share count fell 0.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Noah Holdings Ltd can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $551M | $684M | $784M | $698M | $717M |
| Current ratio | 2.4x | 3.3x | 3.8x | 4.5x | 4.5x |
| Quick ratio | 2.4x | 3.3x | 3.8x | 4.5x | 4.5x |
| Total assets | $1.7B | $1.7B | $1.8B | $1.6B | $1.7B |
| Total liabilities | $433M | $333M | $318M | $242M | $251M |
| Shareholders' equity | $1.3B | $1.4B | $1.5B | $1.4B | $1.4B |
| Net debt (− = net cash) | — | — | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✓ | ✕ | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ | ✓ |
| Cash from operations exceeds net income | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✕ | ✓ |
| Debt fell relative to assets | — | — | — | — | — | — | — | — | — | — |
| Current ratio rose | — | ✕ | ✓ | ✓ | ✕ | ✕ | ✓ | ✓ | ✓ | ✕ |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✓ |
| Gross margin rose | — | — | — | — | — | — | — | — | — | — |
| Revenue rose relative to assets | — | ✕ | ✓ | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ | ✕ |
| F-score | — / 3 | 3 / 7 | 5 / 7 | 4 / 7 | 2 / 7 | 5 / 7 | 3 / 7 | 4 / 7 | 3 / 7 | 5 / 7 |
| Accruals ratio | −0.7% | 2.1% | −3.0% | −5.2% | −15.7% | −2.0% | 3.0% | −2.5% | 0.7% | −3.5% |
| Altman Z'' | 7.06 | 6.80 | 8.62 | 9.52 | 9.16 | 7.30 | 8.94 | 9.73 | 10.72 | 10.67 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $214M | $199M | $497M | $491M | $479M | $666M | $460M | $465M | $361M | $363M |
| Provision for credit losses | $0.2M | $0.5M | $0.4M | $1.1M | $1.3M | $15.4M | — | — | — | — |
| Operating income | $100M | $115M | $140M | $132M | $182M | $186M | $162M | $155M | $88.1M | $108M |
| Pretax income | $110M | $129M | $153M | $140M | −$84.8M | $201M | $171M | $171M | $121M | $119M |
| Income tax | $23.8M | $29.5M | $33.6M | $31.8M | $37.4M | $45.6M | $39.7M | $37.0M | $37.3M | $41.4M |
| Net income | $96.9M | $113M | $123M | $120M | −$108M | $204M | $145M | $143M | $66.1M | $77.8M |
| Net income to common | $96.9M | $113M | $123M | $120M | −$108M | $204M | $145M | $143M | $66.1M | $77.8M |
| Diluted EPS | $16.62 | $19.16 | $20.15 | $19.42 | −$17.40 | $3.02 | $2.12 | $2.05 | $0.94 | $1.11 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B |
| Cash flow | ||||||||||
| Cash from operations | $103M | $93.0M | $156M | $186M | $115M | $236M | $94.0M | $186M | $53.8M | $136M |
| Capital expenditure | $15.3M | $22.6M | $19.4M | $9.5M | $7.5M | $352M | $9.3M | $22.3M | $11.4M | $18.7M |
| Free cash flow | $88.0M | $70.4M | $136M | $177M | $108M | −$116M | $84.7M | $164M | $42.4M | $117M |
| Depreciation and amortization | $9.2M | $12.1M | $13.9M | $15.3M | $14.3M | $22.7M | $23.2M | $22.3M | $21.8M | $21.8M |
| Stock-based compensation | $11.9M | $13.9M | $17.0M | $13.7M | $8.7M | $7.9M | $6.3M | $1.6M | $15.2M | $9.3M |
| Acquisitions | — | — | $29.2M | $1.2M | −$1.2M | $4.3M | — | $3.5M | — | $7.0M |
| Share buybacks | $1.9M | $4.6M | — | — | $40.8M | $57.7M | — | — | $7.4M | $7.3M |
| Dividends paid | — | — | — | — | — | — | — | $25.1M | $140M | $76.1M |
| Dividends and buybacks | $1.9M | $4.6M | — | — | $40.8M | $57.7M | — | $25.1M | $147M | $83.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $473M | $318M | $459M | $727M | $783M | $551M | $684M | $784M | $698M | $717M |
| Current assets | $681M | $620M | $742M | $967M | $1.0B | $868M | $916M | $1.0B | $887M | $909M |
| Current liabilities | $227M | $280M | $231M | $216M | $288M | $359M | $276M | $266M | $196M | $204M |
| Property and equipment, net | $35.1M | $46.6M | $50.4M | $42.6M | $38.0M | $406M | $360M | $349M | $326M | $337M |
| Total assets | $858M | $998M | $1.2B | $1.4B | $1.4B | $1.7B | $1.7B | $1.8B | $1.6B | $1.7B |
| Total liabilities | $322M | $305M | $267M | $277M | $325M | $433M | $333M | $318M | $242M | $251M |
| Shareholders' equity | $480M | $681M | $849M | $1.0B | $1.1B | $1.3B | $1.4B | $1.5B | $1.4B | $1.4B |
| Margins | ||||||||||
| Operating margin | 46.9% | 57.7% | 28.2% | 27.0% | 38.1% | 27.9% | 35.1% | 33.3% | 24.4% | 29.8% |
| EBITDA margin | 51.2% | 63.8% | 31.0% | 30.1% | 41.0% | 31.3% | 40.1% | 38.1% | 30.4% | 35.8% |
| Net margin | 45.2% | 56.7% | 24.7% | 24.4% | −22.5% | 30.6% | 31.5% | 30.6% | 18.3% | 21.4% |
| FCF margin | 41.1% | 35.3% | 27.4% | 36.1% | 22.5% | −17.5% | 18.4% | 35.2% | 11.7% | 32.3% |
| Returns | ||||||||||
| Return on capital employed | 15.9% | 16.0% | 15.0% | 11.1% | 15.9% | 13.7% | 11.3% | 10.2% | 6.2% | 7.3% |
| Return on equity | 20.2% | 19.5% | 16.0% | 12.9% | −10.3% | 17.2% | 11.0% | 10.1% | 4.7% | 5.6% |
| Return on assets | 11.3% | 12.2% | 11.3% | 9.3% | −7.6% | 12.9% | 8.5% | 8.2% | 3.9% | 4.7% |
| Return on tangible equity | 20.2% | 16.6% | 14.4% | 11.9% | −9.8% | 16.1% | 10.6% | 9.8% | 4.8% | 5.5% |
| Growth | ||||||||||
| Revenue growth | — | −7.0% | 149.5% | −1.3% | −2.4% | 39.0% | −30.8% | 1.0% | −22.3% | 0.5% |
| Net income growth | — | 16.5% | 8.6% | −2.1% | −190.0% | — | −28.8% | −1.7% | −53.6% | 17.7% |
| EPS growth | — | 15.3% | 5.2% | −3.6% | −189.6% | — | −29.6% | −3.3% | −54.3% | 17.9% |
| FCF growth | — | −20.0% | 93.5% | 29.9% | −39.0% | −207.7% | — | 93.4% | −74.1% | 176.4% |
| Share count change | — | 0.7% | 1.6% | 0.7% | 0.3% | 989.0% | 1.2% | 1.6% | 1.4% | −0.1% |
| Financial health | ||||||||||
| Current ratio | 3.0x | 2.2x | 3.2x | 4.5x | 3.6x | 2.4x | 3.3x | 3.8x | 4.5x | 4.5x |
| Quick ratio | 3.0x | 2.2x | 3.2x | 4.5x | 3.6x | 2.4x | 3.3x | 3.8x | 4.5x | 4.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 7.1% | 11.3% | 3.9% | 1.9% | 1.6% | 52.9% | 2.0% | 4.8% | 3.2% | 5.1% |
| Stock comp / revenue | 5.6% | 7.0% | 3.4% | 2.8% | 1.8% | 1.2% | 1.4% | 0.4% | 4.2% | 2.6% |
| Payouts / FCF | 2.2% | 6.6% | — | — | 37.8% | — | — | 15.3% | 347.7% | 71.1% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 3.0 | 5.0 | 4.0 | 2.0 | 5.0 | 3.0 | 4.0 | 3.0 | 5.0 |
| Altman Z'' | 7.1 | 6.8 | 8.6 | 9.5 | 9.2 | 7.3 | 8.9 | 9.7 | 10.7 | 10.7 |
| Accruals ratio | −0.7% | 2.1% | −3.0% | −5.2% | −15.7% | −2.0% | 3.0% | −2.5% | 0.7% | −3.5% |
Source: SEC EDGAR XBRL filings (CIK 0001499543). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in CNY under US GAAP and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. Per-share figures are per US-listed share (1 ADS = 5 ordinary shares). For information only — not investment advice. Check the original filings before relying on any figure.
